Topical oestrogens used for atrophic vaginitis should be used in the minimum effective amount, to minimise absorption and systemic effects. They should be used on a short-term basis.
If used on a longer-term basis, there may be a risk of endometrial hyperplasia but this is uncertain. Treatment should be reviewed at least annually.
Replens MD® is a non-hormonal moisturising vaginal gel for symptoms of vaginal dryness, atrophy and urogenital change. It should be considered before prescribing hormone-containing products. This can be purchased by patients as an OTC product.